Archives: Speakers

Lightbox Wealth CEO and co-founder Phil Watson is an investment executive and entrepreneur focused on helping family offices, wealth managers, and institutional investors make better investment decisions through technology, governance, and data intelligence. Formerly a Managing Director at Citi, Phil held senior leadership roles spanning investment strategy, innovation, and client solutions, including serving as Global Head of the Investment Lab and Chief Innovation Officer within wealth management.

Phil now leads Lightbox Wealth, a firm dedicated to delivering “simpler, smarter, safer” investment decisioning capabilities through its Optimised-CIO platform. His work focuses on combining institutional-grade governance, portfolio analytics, AI, and decision architecture to support family offices and professional investors in navigating increasingly complex markets.

A regular speaker on wealth management, AI, and investment governance, Phil is passionate about transforming how investment organisations operate – moving from fragmented reporting toward proactive, intelligent decision environments.

Junior is an award-winning executive coach, facilitator, and experienced ERG leader with over 18 years’ experience in the financial services industry and leadership.

He works with senior leaders, and individuals from the global majority to unlock their potential and excel in their careers.

He is also a peer mentor for the NHS, and community volunteer for African Rainbow Family, supporting LGBT people seeking asylum and refugees with access to healthcare and navigating life in the UK.

Junior hosts the annual Black Voices in Coaching Research Conference and has spoken at large scale events globally.

He applies an inclusive lens to all that he does, promoting a culture of acceptance without exception, tackling systemic barriers, cultural intelligence, and unconscious bias – and has been listed on the INvolve Role Models list for the past three years and recognised in the LGBT Awards, Ethnicity Awards and most recently the Black Talent Awards.

He was diagnosed in 2014 and has been undergoing treatment for the disease for most of the intervening years. Paul is co-leader of the San Francisco Bay Area Multiple Myeloma Support Group. He is the patient advocate on the Myeloma Committee for the South West Oncology Group providing input into clinical trial concepts and execution. Paul is also a member of the Multiple Myeloma Patient Collaborative Team with the American Society of Hematology. He serves as a patient reviewer for grant applications made to the Congressionally Directed Medical Research Program of the Department of Defense. Paul retired in 2019 after a 34-year career in pharmaceutical R&D with Pfizer, Roche and Genentech. The first half of Paul’s career was in Drug Discovery as a Research Scientist and Project Leader. The second half spanned all phases of drug development and post-marketing. He was a Global Project Manager on cross-functional drug development teams and a Director in late-stage Clinical Operations and in US Medical Affairs. 

Dr. Nick Vyas is a renowned educator and a visionary leader in supply chain management. He serves as the Founding Executive Director of the USC Marshall Randall R. Kendrick Global Supply Chain  

Institute and the Academic Director of the USC Master of Science in Global Supply Chain  

Management program. Additionally, as a full-time Professor of Clinical Data Sciences and Operations at USC Marshall, he is dedicated to shaping and inspiring the next generation of global supply chain  

Leaders. Prof. Vyas’s sharp insights have made him a trusted voice across major media platforms, including Reuters, MSNBC, Bloomberg, Fox News, Voice of America, CGTN, and Business Insider. Renowned for his ability to untangle the complexities of global trade and supply chains, he is frequently sought after for his clear, compelling analyses. His skill in breaking down intricate issues into accessible, enlightening commentary has solidified his reputation as a go-to expert. His notable works, including Enterprise Excellence and Blockchain and the Supply Chain, 2nd Edition, explore the transformative impact of cutting-edge technologies. These publications have become essential references for industry professionals, offering valuable insights and practical guidance. The latest book, “Supply Chain Network Design: How to Create Resilient, Agile and Sustainable Supply Chains,” which he co-authored, offers insights into building agile supply chains in the face of geopolitical changes and technological advancements. It emphasizes a global outlook, ESG objectives, and the circular economy. The book explores the role of emerging technologies, such as Artificial Intelligence (AI), Machine Learning (ML), Blockchain, and automation, in providing a competitive advantage and enhancing network design with sophisticated forecasting methods. 

Dr. Siamak Zadeh is a Professor, Data Scientist, and serial innovator at Golden Gate University (GGU) in San Francisco, where he serves as Director of the University’s AI Initiative. Combining academic rigor with entrepreneurial drive, he leads efforts to bridge the gap between artificial intelligence research, business transformation, and real-world impact. Beyond academia and industry, Dr. Zadeh is the Co-Founder and Chief Technology Officer (CTO) at CareImpact.ai, a startup offering CareAgent360 – a platform that applies AI and agentic automation to healthcare coordination and benefit management. His entrepreneurial work focuses on using AI to address systemic inefficiencies, reduce healthcare disparities, and improve outcomes for underserved communities.

Dr Mishra (Ex Genentech, Ex NCI, Ex NIH) is the founding president and CEO of the American Association for Precision Medicine ( and chair of ACT AAPM’s Coronavirus Taskforce He is leading research efforts focused on preventing curing chronic diseases not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives 

He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company committed to revolutionizing drug discovery development through technology, big data, robotics, and artificial intelligence He is a serial entrepreneur who founded his first company after graduating high school, and his second company during his Ph D Since then, he has accumulated a wealth of experience by building, investing, and advising numerous other companies He is an investor, co founder/ board member of a few corporations, focused on accelerating drug discovery/ development, data analytics, robotics, mental health, and digital health He is also the founder of AAPM Angels and Investors AAi an investment group focused on investing in drug discovery, diagnostics, precision medicine, technology healthcare companies He is also the founding investor and advisor to Barcelona Ventures and serves as an advisor to a 100 M private equity fund 

Widely recognized as a thought leader in the field of ‘technology and healthcare’, Dr Mishra has keynoted, chaired, curated, and organized numerous successful international conferences He served as a Scientist and Principal Investigator at the pharma giant Genentech, Roche Where he participated in several drug discovery project teams Moreover, his passion for drug development and precision medicine has led to the identification of new drug targets, biomarkers, companion diagnostics, and several drugs/ combinations in the clinic 

His research work has been recognized globally by over 40 prestigious awards and honors Due to his unique perspective selfless service, he is a highly respected sought after mentor to many The companies that he has advised have raised multimillion dollars Notably, he serves as a mentor and advisor to several VC funds and startup accelerators, including IndieBio HIMSS/Health 2 0 ’s Project Zygote, MedLabs ZGC Capital, J&J JLabs UCSF Innovation Venture, UCSF Invent Fund, and California Life Sciences’s FAST program, to help grow California’s life sciences innovation ecosystem 

Jamie Goldman is the Logistics Program Manager at Orca Bio, where she oversees the end-to-end logistics of life-saving cell therapies to ensure delivery accuracy and reliability across a growing portfolio of onboard-carried shipments. With over 10 years of experience across biotech, e-commerce, and aviation—including leadership roles at Amazon, Redbubble, and United Airlines—Jamie has built a career driving measurable operational improvements through data-driven decision-making and people-centered leadership. At Orca Bio and Thistle, she has championed integrating AI-powered tools to streamline supply chain planning, strengthen inventory management, and accelerate the adoption of continuous improvement initiatives. Whether managing 75 frontline associates on the warehouse floor, identifying a $1.5M cost-saving opportunity through deep data analysis, or developing training programs with 90%+ adoption rates, Jamie brings the same commitment to precision and people to every challenge. She is a passionate advocate for building resilient, technology-enabled supply chains that keep both operations and teams performing optimally.